{"organizations": [], "uuid": "df16ba6621d3df2f4b705ada6ce79a4b674e1c69", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.reuters.com", "main_image": "https://s4.reutersmedia.net/resources_v2/images/rcom-default.png", "site_section": "http://feeds.reuters.com/reuters/companyNews", "section_title": "Reuters: Company News", "url": "https://www.reuters.com/article/us-sinocare-m-a/chinas-sinocare-in-deal-talks-it-says-after-reported-interest-in-jj-unit-idUSKBN1FC1DY", "country": "US", "domain_rank": 408, "title": "China's Sinocare in deal talks, it says after reported interest in J&J unit", "performance_score": 0, "site": "reuters.com", "participants_count": 1, "title_full": "", "spam_score": 0.019, "site_type": "news", "published": "2018-01-23T19:41:00.000+02:00", "replies_count": 0, "uuid": "df16ba6621d3df2f4b705ada6ce79a4b674e1c69"}, "author": "Reuters Editorial", "url": "https://www.reuters.com/article/us-sinocare-m-a/chinas-sinocare-in-deal-talks-it-says-after-reported-interest-in-jj-unit-idUSKBN1FC1DY", "ord_in_thread": 0, "title": "China's Sinocare in deal talks, it says after reported interest in J&J unit", "locations": [], "entities": {"persons": [{"name": "kane wu", "sentiment": "none"}, {"name": "david goodman", "sentiment": "none"}], "locations": [{"name": "china", "sentiment": "none"}, {"name": "u.s.", "sentiment": "none"}], "organizations": [{"name": "reuters", "sentiment": "negative"}, {"name": "hong kong", "sentiment": "negative"}, {"name": "sinocare inc", "sentiment": "negative"}, {"name": "j&j", "sentiment": "negative"}, {"name": "china investment corp", "sentiment": "none"}, {"name": "johnson & johnson", "sentiment": "none"}, {"name": "china jianyin investment", "sentiment": "none"}]}, "highlightText": "", "language": "english", "persons": [], "text": "HONG KONG (Reuters) - Chinese medical company Sinocare Inc ( 300298.SZ ) is in preliminary talks on a potential deal, it said on Tuesday after Reuters reported last week that it was a potential bidder for U.S. group Johnson & Johnsonâ€™s ( JNJ.N ) diabetes care business.\nReuters reported on Jan. 17 that a consortium of Sinocare and China Jianyin Investment, owned by sovereign wealth fund China Investment Corp, has hired an adviser to work on a possible deal with J&J worth up to $4 billion.\nSinocare, which develops and manufactures blood sugar monitoring systems, said in a stock exchange filing that it had hired advisers to study the structure and pricing of a potential transaction but had not submitted any binding bid to the potential seller nor reached any agreement.\nThe company said there is no timetable for a bidding process and no guarantee that talks would continue.\nSinocare, which suspended trading of its shares on Jan. 18, will resume trading tomorrow, it said.\nReporting by Kane Wu; Editing by David Goodman\n ", "external_links": ["http://thomsonreuters.com/en/about-us/trust-principles.html"], "published": "2018-01-23T19:41:00.000+02:00", "crawled": "2018-01-23T14:00:49.000+02:00", "highlightTitle": ""}